MEDIPOST Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.054x

MEDIPOST Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has a cash flow conversion efficiency ratio of -0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-14.44 Billion ≈ $-9.78 Million USD) by net assets (₩265.17 Billion ≈ $179.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of MEDIPOST Co. Ltd (2011–2024)

Cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024. This chart illustrates how MEDIPOST Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MEDIPOST Co. Ltd share price for real-time trading data and today's change.

MEDIPOST Co. Ltd Cash Flow Conversion Ratio Explained

MEDIPOST Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

MEDIPOST Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDIPOST Co. Ltd ranked by their cash flow conversion efficiency. Also see MEDIPOST Co. Ltd (078160) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
DeFi Development Corp. NASDAQ:DFDV	-0.963x
Yusin Holding Corp TW:4557	0.042x
IF Bancorp Inc NASDAQ:IROQ	0.018x
Carlo Gavazzi Holding AG SW:GAV	0.020x
Bien Sparebank ASA OL:BIEN	0.207x
Lexinfintech Holdings Ltd NASDAQ:LX	0.081x
Grange Resources Ltd AU:GRR	0.038x
Gongin Precision Industrial Co Ltd TWO:3178	0.072x

Annual Cash Flow Conversion Efficiency for MEDIPOST Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024. Review 078160 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩252.60 Billion ≈ $171.18 Million	₩-37.27 Billion ≈ $-25.25 Million	-0.148x	-142.55%
2023-12-31	₩313.66 Billion ≈ $212.56 Million	₩-19.08 Billion ≈ $-12.93 Million	-0.061x	-76.79%
2022-12-31	₩179.97 Billion ≈ $121.96 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.034x	-235.26%
2021-12-31	₩159.48 Billion ≈ $108.08 Million	₩4.06 Billion ≈ $2.75 Million	0.025x	+66.11%
2020-12-31	₩116.54 Billion ≈ $78.98 Million	₩1.78 Billion ≈ $1.21 Million	0.015x	-77.26%
2019-12-31	₩111.59 Billion ≈ $75.62 Million	₩7.51 Billion ≈ $5.09 Million	0.067x	+23.88%
2018-12-31	₩126.81 Billion ≈ $85.94 Million	₩6.89 Billion ≈ $4.67 Million	0.054x	+181.97%
2017-12-31	₩104.45 Billion ≈ $70.78 Million	₩-6.93 Billion ≈ $-4.69 Million	-0.066x	+23.49%
2016-12-31	₩143.31 Billion ≈ $97.12 Million	₩-12.42 Billion ≈ $-8.42 Million	-0.087x	-83.84%
2015-12-31	₩146.48 Billion ≈ $99.27 Million	₩-6.91 Billion ≈ $-4.68 Million	-0.047x	-270.60%
2014-12-31	₩117.34 Billion ≈ $79.52 Million	₩-1.49 Billion ≈ $-1.01 Million	-0.013x	-229.63%
2011-12-31	₩115.04 Billion ≈ $77.96 Million	₩1.13 Billion ≈ $765.03K	0.010x	--

About MEDIPOST Co. Ltd

KQ:078160 Korea Biotechnology & Medical Research

Market Cap

$86.09 Million

₩127.04 Billion KRW

Market Cap Rank

#19592 Global

#996 in Korea

Share Price

₩8260.00

Change (1 day)

+2.10%

52-Week Range

₩7520.00 - ₩28000.00

All Time High

₩72522.12